To this end, we constructed a doxycycline inducible shRNA lentiviral vector targeting both β-TrCP1 and β-TrCP2 with which we transduced the two androgen-sensitive human prostate cancer cell lines, LNCaP and LAPC4. The gene discussed is BTRC; the disease is prostate carcinoma.